Clinical Trial Update: Evaluation of Side Effects of Mitotane

View source ↗

Summary

A clinical trial update on evaluating the side effects of mitotane in patients with adrenocortical carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• LYSODREN (MITOTANE)

Snippet

Sponsor: University of Wuerzburg | Conditions: Adrenocortical Carcinoma | Status: ACTIVE_NOT_RECRUITING